Teva Bows To $1.4bn US Ingrezza IP With Far Future Settlement

Israeli Firm Must Wait To Broaden TD Portfolio With Distant Settlement Deal

TEVA
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin